Premium
Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride
Author(s) -
Karges B.,
Schnur D.,
Ellard S.,
Kentrup H.,
Karges W.
Publication year - 2012
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.2011.03487.x
Subject(s) - medicine , glimepiride , diabetes mellitus , mutation , type 2 diabetes , sulfonylurea receptor , pharmacology , endocrinology , genetics , glibenclamide , gene , biology
Diabet. Med. 29, 692–693 (2012)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom